ESC Premium Access

The future of preventing reperfusion injury: achievable anytime soon?


About the speaker

Doctor Duane Pinto

Beth Israel Deaconess Medical Center, Boston (United States of America)
3 presentations
0 follower

4 more presentations in this session

No-reflow: prevention and pathophysiology - State of the art

Speaker: Doctor P. Wenzel (Mainz, DE)


The modulation of miR-129-3p levels in coronary thrombi after primary PCI discloses a novel potential mechanism underlying the no reflow phenomenon

Speaker: Doctor S. De Rosa (Catanzaro, IT)


Impaired endogenous fibrinolysis in STEMI patients undergoing PPCI is an independent predictor of recurrent cardiovascular events -the RISK PPCI study

Speaker: Doctor M. Farag (Cambridge, GB)


Multicenter randomized clinical trial of the efficacy and safety of intravenous quercetin in patients with ST-elevation acute myocardial infarction

Speaker: Doctor S. Kozhukhov (Kiev, UA)


Access the full session

No-reflow prevention and pathophysiology

Speakers: Doctor D. Pinto, Doctor P. Wenzel, Doctor S. De Rosa, Doctor M. Farag, Doctor S. Kozhukhov

About the event


ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Related content

ESC Premium Access

SGLT2 inhibitors in heart failure: adjusting other treatments and what to tell the patient.

30 August 2021

ESC Premium Access

Who should be treated with an SGLT2 inhibitor?

30 August 2021

ESC Premium Access

Acute myocardial infarction with cardiogenic shock: case presentation.

29 August 2021

This platform is supported by

logo Novo Nordisk